Maryland 2006 3-way Senate Debate: on Abortion

Benjamin Cardin: Embryonic research holds promise for reversing diseases

A: Parents should be involved in the decisions of their children. Absolutely. But there are some families where there has been abuse, there are some families where there’s been neglect, if there is proper protection in the law, then let’s take a look at it. phony divide. But I am concerned this may be one more corporate boondoggle. We already provide more than $300 billion in corporate welfare to wealthy companies. If we’re going to provide funding for stem-cell research, then taxpayers should be treated as investors and should profit from that research.

CARDIN: Most stem-cell research is done by universities, with the support of NIH. Embryonic stem-cell research holds promise not only for stopping the deterioration for diseases, but for reversing it.

Kevin Zeese: Fund both adult and embryonic stem-cell research

STEELE: I am four-square for stem-cell research, and accelerating the funding, with respect to cord blood and adult stem cell research. But I draw the line at embryonic research because I respect the life that that embryo represents.

ZEESE: I agree with the need for adult stem-cell research because I think science may find that mature cells are better than embryonic. But I also support embryonic, because we need to move forward, and avoid this phony divide. But I am concerned this may be one more corporate boondoggle. We already provide more than $300 billion in corporate welfare to wealthy companies. If we’re going to provide funding for stem-cell research, then taxpayers should be treated as investors and should profit from that research.

CARDIN: Most stem-cell research is done by universities, with the support of NIH. Embryonic stem-cell research holds promise not only for stopping the deterioration for diseases, but for reversing it.

Michael Steele: More funding for adult stem-cell research, but not embryonic

STEELE: I am four-square for stem-cell research, and accelerating the funding, with respect to cord blood and adult stem cell research. But I draw the line at embryonic research because I respect the life that that embryo represents.

ZEESE: I agree with the need for adult stem-cell research because I think science may find that mature cells are better than embryonic. But I also support embryonic, because we need to move forward, and avoid this phony divide. But I am concerned this may be one more corporate boondoggle. We already provide more than $300 billion in corporate welfare to wealthy companies. If we’re going to provide funding for stem-cell research, then taxpayers should be treated as investors and should profit from that research.

CARDIN: Most stem-cell research is done by universities, with the support of NIH. Embryonic stem-cell research holds promise not only for stopping the deterioration for diseases, but for reversing it.